Tokyo, Jan. 30 (Jiji Press)--Japan's Takeda Pharmaceutical Co. said Thursday that its president and CEO, Christophe Weber, will step down at its general shareholders meeting in June 2026.

Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years. The company called the ...

Julie Kim is set to replace Christophe Weber as the new CEO of Takeda Pharmaceutical, becoming the first woman to lead the more than 240-year-old Japanese drugmaker. Kim, 54, has been running ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

The USGS says once a body’s temperature reaches 95 degrees, a person’s agility and self-rescue abilities become virtually non-existent, which is why people who fall into cold waters can die ...

This intensifying heat has made air conditioning in vehicles more of a necessity than a luxury. Whether your air conditioning system is blowing warm air, making strange noises, or not blowing ...

Say your engine is at its normal operating temperature, the heater is turned on, the temperature is set to something warm and cozy, and you can only feel cold air blowing out of the vents.

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous ...

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

The best air fryers could completely change your food preparation. Air fryers need a lot less oil than you'd use for regular frying, which means you'll get healthier food that's just as delicious ...

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...